Two-year follow-up after percutaneous coronary intervention with titanium-nitride-oxide-coated stents versus paclitaxel-eluting stents in acute myocardial infarction

By Karjalainen Pasi   Ylitalo Antti   Niemela Matti   Kervinen Kari   Makikallio Timo   Pietila Mikko   Sia Jussi   Tuomainen Petri   Nyman Kai   Airaksinen K. E. Juhani  

Annals of Medicine, Vol. 41, Iss. 8, 2009-01 ,pp. : 599-607

Informa Healthcare

Access to resources Recommend Favorite

Primary percutaneous coronary intervention by drug‐eluting balloon angioplasty: The nonrandomized fourth arm of the DEB‐AMI (drug‐eluting balloon in ST‐segment elevation myocardial infarction) trial

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 86, Iss. S1, 2015-10 ,pp. : S34-S44

John Wiley & Sons Inc

Access to resources Recommend Favorite

Periprocedural use of tirofiban in elective percutaneous coronary intervention for long coronary lesions in stable patients with overlapping drug‐eluting stents—the PETITION study: A prospective, randomized, multicenter study

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 85, Iss. S1, 2015-03 ,pp. : 762-769

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of percutaneous coronary intervention with drug‐eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five‐years after intervention

By  

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, Vol. 84, Iss. 7, 2014-12 ,pp. : 1029-1039

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of high lipoprotein(a) levels on in‐stent restenosis and long‐term clinical outcomes of angina pectoris patients undergoing percutaneous coronary intervention with drug‐eluting stents in Asian population

By  

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (ELECTRONIC), Vol. 42, Iss. 6, 2015-06 ,pp. : 588-595

John Wiley & Sons Inc

Access to resources Recommend Favorite